« Return to News | CROs/Service Providers

Medpace Buys Medical Device CRO Symbios

Wednesday, April 7, 2010 01:55 PM

Cincinnati-based contract research organization (CRO) Medpace acquired medical device CRO Symbios for an undisclosed amount. Symbios was advised by Fairmount Partners in this transaction.

Symbios supports medical device research with experience in pre-market, post-approval and post-market clinical trials. The company will continue to operate out of its Minneapolis, Minn., headquarters. Symbios’ founder and CEO Ryan Wilson and his management team will continue to lead Medpace’s medical device business, now named Symbios Clinical, as a member of the Medpace group of companies.

“The ability of Medpace to tap into this innovative company for benefit of our existing and new Sponsors will be valuable as yet another service area for Medpace, and allow Symbios to benefit from our established global infrastructure,” said Medpace president and CEO August Troendle in a statement.

Medpace offers services in phase I to IV clinical trial management, bio-imaging, central laboratory and clinical pharmacology. The CRO has European headquarters in The Netherlands, Asian headquarters in Singapore and regional offices throughout Europe, Asia, Australia, South Africa and the Americas.

Earlier this year, the company acquired Germany-based CRO Medical Consulting Dr. Schlichtiger. At the time, Medpace had 1,000 employees worldwide but announced plans to almost double its headcount by 2014.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.